Experience

Widler & Schiemann AG

• Switzerland
• Business Consulting and Services
• 1 - 100 Employee

• Managing Partner

  • Mar 2012 - 11 years 10 months

  Zug, Switzerland Widler & Schiemann Ltd. are customer focused thought- leaders in clinical development with offices in Switzerland, the USA and China. Our 21 Partners and Associate Partners have on average 20 years of experience in the pharmaceutical and biotech industry or regulatory authorities. With this vast expertise and diversity in specialization, we support our clients in all aspects of drug development from drug development strategies (i.e. Target Product Profiles), Clinical Development Plans and… Show more Widler & Schiemann Ltd. are customer focused thought- leaders in clinical development with offices in Switzerland, the USA and China. Our 21 Partners and Associate Partners have on average 20 years of experience in the pharmaceutical and biotech industry or regulatory authorities. With this vast expertise and diversity in specialization, we support our clients in all aspects of drug development from drug development strategies (i.e. Target Product Profiles), Clinical Development Plans and pre-clinical studies to post approval commitment trials as well as technical development and scale up. Show less



Ymmunobio

• Switzerland
• Biotechnology Research
• 1 - 100 Employee

• CEO & Chairman of the Board

  • Sep 2021 - 2 years 4 months

  Riehen, Basel, Switzerland Ymmunobio is developing a proprietary class of CEACAM1* immune agonistic antibodies. These antibodies have a direct co-stimulatory effect on immune cells in addition to interfering with the CEACAM1-CEACAM mediated check-point blockade. We are utilizing our proprietary platform to employ the immune system to fight cancer.



iQure Pharma Inc.

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Co-Founder & Member Board Of Directors

  • Apr 2022 - 1 year 9 months

  iQure Pharma is a US-based, global biotech company created by entrepreneurs and former Pharma managers focused on the development of new therapeutics for neuropathic pain, an indication with a high unmet medical need.

• Co-Founder & Chairman Of The Board

  • Jan 2019 - Apr 2022

  Greater New York City Area



LSCP Life Sciences Consulting Partners

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Associate Partner

  • Dec 2014 - 9 years 1 month

  Zürich Area, Switzerland



Roche

• Switzerland
• Biotechnology Research
• 700 & Above Employee

• Global Head of Quality Risk Management

  • Jun 2009 - Jan 2012

  Switzerland

• Project Leader

  • Mar 2003 - May 2009

  United States of America and Switzerland



PwC

• Professional Services
• 700 & Above Employee

• Consultant

  • Aug 1999 - Feb 2003

  Switzerland and United States of America



Roche

• Switzerland
• Biotechnology Research
• 700 & Above Employee

• Global Head of IMP Packaging and Labeling

  • May 1997 - Jul 1999

  Switzerland

• Group Leader In-Process Control Trade Packaging

  • Jan 1996 - Apr 1997

  Switzerland



The Philipp University of Marburg

• Higher Education
• 700 & Above Employee

• Project Leader

  • Apr 1992 - Dec 1995

  Germany